USPRX Financials | Key Metrics & Investor Analysis
The financial statements for USPRX (USPRX) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| TRRBX T. Rowe Price Retirement 2020 Fund | $20.43 -0.63% |
| PRITX T. Rowe Price International Stock | $21.93 -1.62% |
| R Ryder System, Inc. | $227.58 -1.47% |
| PRHSX T. Rowe Price Health Sciences Fund | $80.77 -0.90% |
| WFMDX Allspring Special Mid Cap Value Fund | $49.24 -0.38% |
| TRMCX T. Rowe Price Mid-Cap Value Fund | $35.71 -0.70% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| TRRBX T. Rowe Price Retirement 2020 Fund | $20.43 | -0.63% | 12.81 B | 22.96 | 0.89 | 5.85% | — | 0 |
| PRITX T. Rowe Price International Stock | $21.93 | -1.62% | 12.79 B | 22.41 | 0.98 | 9.29% | — | 0 |
| R Ryder System, Inc. | $227.58 | -1.47% | 8.97 B | 18.98 | 11.99 | 1.56% | Buy | 516 |
| PRHSX T. Rowe Price Health Sciences Fund | $80.77 | -0.90% | 13.10 B | 28.89 | 2.80 | 12.48% | — | 0 |
| WFMDX Allspring Special Mid Cap Value Fund | $49.24 | -0.38% | 12.80 B | 22.19 | 2.22 | 10.19% | — | 0 |
| TRMCX T. Rowe Price Mid-Cap Value Fund | $35.71 | -0.70% | 15.81 B | 20.56 | 1.74 | 4.89% | — | 0 |
Frequently Asked Questions
What are USPRX's latest financial results?
Review USPRX's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has USPRX's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is USPRX's cash flow situation and liquidity?
Cash flow statements reveal how USPRX generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does USPRX's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether USPRX is outperforming or lagging within its sector.
Are USPRX's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether USPRX's profits are repeatable and supported by strong fundamentals.